Lack of weight loss after 4 weeks on semaglutide is completely normal. The 0.25 mg starting dose is designed to acclimate your body to GLP-1 effects with minimal side effects, not to produce significant weight loss. Average weight loss at this dose is only 1-3 pounds. Significant loss appears at higher doses, typically beginning around week 9 when most patients reach the 1.0 mg dose. The 4-week mark is a checkpoint for tolerability, not for weight-loss results.
Why the Starting Dose Produces So Little Weight Loss
The 0.25 mg starting dose is roughly one-tenth of the maximum 2.4 mg maintenance dose. At this low dose:
- GLP-1 receptor engagement is partial
- Appetite suppression is mild
- The effect on stomach emptying is modest
- The drug is still accumulating toward steady-state blood levels (about 5 weeks at any given dose)
The dose is intentionally subtherapeutic to allow your body to acclimate to GLP-1 effects. Starting at the maintenance dose would cause severe nausea and intolerable side effects in most patients. The slow titration is a feature, not a flaw.
STEP-1 Trial Weight Loss Timeline
The STEP-1 trial showed weight loss progression over time:
| Week | Dose Phase | Average % Weight Loss |
|---|---|---|
| 4 | 0.25 mg (starting) | ~1-2% |
| 8 | 0.5 mg | ~3-4% |
| 12 | 1.0 mg | ~6% |
| 16 | 1.7 mg | ~8% |
| 20 | 2.4 mg (maintenance) | ~10% |
| 52 | 2.4 mg | ~14% |
| 68 | 2.4 mg | ~15% |
For a 220-pound person, average loss at 4 weeks is 2-4 pounds — barely above day-to-day weight fluctuation.
What You Should Notice at 4 Weeks
Even without significant weight loss, you should notice some of the following at 4 weeks on the 0.25 mg dose:
- Smaller meal portions naturally (you get full faster)
- Reduced interest in snacks between meals
- Decreased “food noise” (background thoughts about food)
- Less interest in foods you previously craved
- Possibly less interest in alcohol
- Some mild GI symptoms (nausea, occasional GI upset)
If you’ve noticed none of these signs of GLP-1 engagement, contact your prescriber. This could indicate a non-response or other issue worth investigating.
How to Use the First 4 Weeks Productively
While waiting for higher doses to produce meaningful weight loss, establish habits that will amplify the drug’s effect:
- Track your food. Use a food tracking app for one week to identify hidden calories — sugary drinks, alcohol, cooking oils, snacking.
- Increase protein intake. Aim for 0.8-1.2 grams per kilogram of body weight per day. Protein preserves muscle during weight loss.
- Start or continue strength training. 2-3 sessions per week. This preserves and builds metabolically active muscle.
- Prioritize sleep. 7-9 hours nightly. Poor sleep raises hunger hormones and works against the drug.
- Stay hydrated. 8+ cups of water daily. Helps manage side effects and supports kidney health.
- Walk more. 7,000+ daily steps. Low-intensity activity adds up without spiking hunger.
Common Concerns at the 4-Week Mark
“I haven’t lost any weight.” Average loss is only 1-3 pounds at this point. Some weeks may show no scale movement. This is normal at the starting dose.
“I’ve gained weight.” Water weight fluctuations, hormonal cycles (in women), constipation (a common semaglutide side effect), and dietary sodium changes can all cause temporary scale increases. Track over weeks, not days.
“The side effects are bad but I’m not losing weight.” The side effects appear at any dose; the weight loss requires higher doses. If side effects are intolerable at the starting dose, talk to your prescriber about slowing titration further or finding alternatives.
“My friend lost 10 pounds in 4 weeks.” Some patients are strong early responders. Your friend’s experience doesn’t predict yours. Average matters more than anecdote.
When to Actually Worry
Contact your prescriber if:
- You have zero appetite reduction at 4 weeks despite full dose adherence
- Side effects are severe enough to interfere with eating or hydration
- You’re experiencing severe abdominal pain (possible pancreatitis)
- You’re vomiting persistently (risk of dehydration and kidney injury)
- You’re worried about whether the drug is working for your specific situation
These are productive reasons to check in. “I haven’t lost much weight in 4 weeks” is not, on its own, a reason for concern.
What to Expect Next
The standard Wegovy escalation:
- Week 5-8: 0.5 mg — possibly more appetite suppression, more weight loss
- Week 9-12: 1.0 mg — meaningful weight loss usually starts here
- Week 13-16: 1.7 mg — accelerated weight loss
- Week 17+: 2.4 mg maintenance — full effect
By week 12, the average trial participant had lost about 6 percent of body weight. By week 20, about 10 percent. Be patient through the titration — the curve gets steeper as the dose climbs.
The Bottom Line
No weight loss at 4 weeks on the 0.25 mg semaglutide starting dose is completely normal. The starting dose is designed to acclimate your body, not produce significant weight loss. Average loss at this point is 1-3 pounds. Use the early weeks to establish habits (protein, strength training, sleep, hydration) that will amplify weight loss when higher doses kick in. Significant loss typically begins around week 9 at the 1.0 mg dose. If you have zero appetite reduction or severe side effects, contact your prescriber. For more on GLP-1 treatment options, see our hub.
